|
US$199.00 ยท In stock
Delivery: <= 3 days. True-PDF full-copy in English will be manually translated and delivered via email.
GBZ94-2017: Diagnosis of occupational malignant tumor
Status: Valid GBZ94: Evolution and historical versions
| Standard ID | Contents [version] | USD | STEP2 | [PDF] delivered in | Standard Title (Description) | Status | PDF |
| GBZ 94-2017 | English | 199 |
Add to Cart
|
3 days [Need to translate]
|
Diagnosis of occupational malignant tumor
| Valid |
GBZ 94-2017
|
| GBZ 94-2014 | English | 319 |
Add to Cart
|
3 days [Need to translate]
|
Diagnosis of occupational malignant tumor
| Obsolete |
GBZ 94-2014
|
| GBZ 94-2002 | English | 239 |
Add to Cart
|
2 days [Need to translate]
|
Diagnostic Criteria of Occupational Cancer
| Obsolete |
GBZ 94-2002
|
PDF similar to GBZ94-2017
Basic data | Standard ID | GBZ 94-2017 (GBZ94-2017) | | Description (Translated English) | Diagnosis of occupational malignant tumor | | Sector / Industry | National Standard | | Classification of Chinese Standard | C60 | | Word Count Estimation | 8,885 | | Date of Issue | 2017-05-18 | | Date of Implementation | 2017-11-01 | | Older Standard (superseded by this standard) | GBZ 94-2014 | | Regulation (derived from) | State-Health-Communication (2017) 5 | | Issuing agency(ies) | General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Standardization Administration of the People's Republic of China | GBZ 94-2002: Diagnostic Criteria of Occupational Cancer---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
Diagnostic Criteria of Occupational Cancer
ICS 13.100
C60
GBZ
People's Republic of China National Occupational Health Standards
Diagnostic criteria for occupational tumors
Released in.2002-04-08
2002-06-01 Implementation
Issued by the Ministry of Health of the People's Republic of China
Foreword
According to the "People's Republic of China Occupational Disease Prevention Law" to develop this standard.
The carcinogenic factors in the production environment are the cause of the excessive incidence of cancer in the workers, long-term exposure to the coke oven in the production process
Flue gas, inorganic arsenic, chloromethyl ether, chromate (manufactured), asbestos, benzidine, benzene, vinyl chloride, etc. may induce specific malignant
Tumor. In order to effectively prevent and treat occupational tumors, protect the health and rights of workers specially formulated this standard.
Appendix A to this standard is an informative appendix.
This standard is proposed and centralized by the Ministry of Health of the People's Republic of China.
This standard by the Chinese Center for Disease Control and Prevention Occupational Health and Poison Control, Fudan University School of Public Health, Anshan
Iron and Steel Company Labor Hygiene Research Institute, Tianjin Bohai Chemical Group Corporation Labor Hygiene Research Institute, Sichuan University Huaxi Public Health
The college is responsible for drafting.
This standard is interpreted by the Ministry of Health of the People's Republic of China.
Diagnostic criteria for occupational tumors
1 Scope
This standard specifies the principles of diagnosis and treatment of occupational tumors.
This standard applies to occupational exposure to asbestos-induced lung cancer, mesothelioma diagnosis and treatment; occupational exposure to benzidine caused by
Diagnosis and treatment of bladder cancer; occupational exposure to benzene caused by the diagnosis and treatment of leukemia; occupational exposure to vinyl chloride-induced hepatic blood vessels
Diagnosis and treatment of sarcoma; occupational exposure to chloromethyl ether, arsenic and its inorganic compounds, coke oven flue gas, chromate (manufacturing)
Diagnosis and treatment of lung cancer.
2 normative reference documents
The terms of the following documents are hereby incorporated by reference into this standard. Any date that references the date of the document
All subsequent amendments (excluding corrigenda) or revisions are not applicable to this standard, however, encouragement under this standard
The parties to the agreement study whether to use the latest version of these documents. Those who do not note the date of the reference file, the latest version of the appropriate
For this standard.
Identification of Occupational Injuries and Occupational Diseases
3 Diagnosis General
3.1 tumor diagnosis is clear
3.1.1 must be primary tumor.
3.1.2 The location of the tumor coincides with the specific target organ of the carcinogen to which it is contacted.
3.1.3 by cytopathology or histopathological examination, or clinical imaging examination, or endoscopic examination and other confirmed.
3.2 There is a clear history of exposure to occupational carcinogens
3.2.1 The age of exposure to carcinogens in accordance with the relevant provisions of the diagnostic rules.
3.2.2 cancer latent period in line with the relevant provisions of the diagnostic rules.
3.2.3 combined with the workplace related to carcinogenic contact status comprehensive judgment.
4 diagnostic rules
4.1 Asbestos-induced lung cancer, mesothelioma
4.1.1 lung cancer
4.1.1.1 diagnosis of primary lung cancer is clear.
4.1.1.2 contact with asbestos dust accumulated length of service for more than 7 years (including 7 years).
4.1.1.3 The latent period is more than 10 years (including 10 years).
4.1.1.4 Asbestos lung with lung cancer can be diagnosed.
4.1.2 mesothelioma
4.1.2.1 must have a cytopathological diagnosis.
4.1.2.2 contact with asbestos dust cumulative length of service for more than 1 year (including 1 year).
4.1.2.3 Potential period of 15 years or more (including 15 years).
4.2 Benzidine-induced bladder cancer
4.2.1 Diagnosis of primary bladder cancer is clear.
4.2.2 production or use of benzidine cumulative contact life of more than 1 year (including 1 year).
4.2.3 latent period of more than 3 years (including 3 years).
4.2.4 benzidine exposure to suffering from renal pelvis, ureteral transitional cell carcinoma can refer to this standard.
4.3 benzene caused by leukemia
4.3.1 confirmed by cytopathology.
4.3.2 Accumulated contact life of benzene operation for more than 1 year (including 1 year).
4.3.3 latent period of more than 1 year (including 1 year).
4.3.4 If the history of chronic benzene poisoning can be diagnosed with leukemia.
4.4 chloromethyl ether caused by lung cancer
4.4.1 diagnosis of primary lung cancer is clear.
4.4.2 Production and use of chloromethyl ether (dichloromethyl ether or industrial monochloromethyl ether) Accumulated contact length of service for more than 1 year (including 1 year).
4.4.3 latent period of more than 4 years (including 4 years).
4.4.4 Workplace formaldehyde, hydrochloric acid and water vapor coexistence caused by dichloromethane induced lung cancer can refer to this standard.
4.5 arsenic caused by lung cancer, skin cancer
4.5.1 lung cancer
4.5.1.1 Diagnosis of primary lung cancer is clear.
4.5.1.2 arsenic mining and smelting cumulative contact length of service for more than 3 years (including 3 years).
4.5.1.3 Potential period of more than 6 years (including 6 years).
4.5.2 skin cancer
4.5.2.1 diagnosis of primary skin cancer is clear.
4.5.2.2 Inorganic arsenic working contact with more than 5 years (including 5 years).
4.5.2.3 Potential period of 5 years or more (including 5 years).
4.5.2.4 history of chronic arsenic poisoning can be diagnosed by skin cancer.
4.6 Vinyl chloride-induced hepatic angiosarcoma
4.6.1 histopathological diagnosis of primary hepatic angiosarcoma.
4.6.2 engaged in the production of PVC, a clear contact history of vinyl chloride monomer, the cumulative contact life of more than 1 year (including 1 year).
4.6.3 latent period of more than 1 year (including 1 year).
4.7 coke workers lung cancer
4.7.1 diagnosis of primary lung cancer is clear.
4.7.2 Coke burner cumulative contact life of more than 1 year (including 1 year).
4.7.3 latent period of more than 10 years (including 10 years).
4.8 chromate manufacturing workers lung cancer
4.8.1 Diagnosis of primary lung cancer is clear.
4.8.2 Accumulated contact with chromate in the manufacture of more than 1 year (including 1 year).
4.8.3 Potential period of 4 years or more (including 4 years).
5 Principles of handling
5.1 Exposure to carcinogens.
5.2 active treatment of malignant tumors, regular review.
5.3 identification of labor capacity, according to GB/T 16180 treatment.
6 Correct use of the description of this standard
See Appendix A (informative).
Appendix A
(Informative)
Correctly use the instructions in this standard
A.1 According to this standard, the patient must be diagnosed with primary tumors.
A.2 Identify the presence of relevant carcinogens in the workplace where the patient is located.
A.3 clear the patient where the workplace has a tumor overrun.
A.4 The tumor site of the patient is consistent with the target organ that is in contact with the carcinogen.
A.5 clinical diagnosis should refer to the previous carcinogen contact status (test records, or corporate raw materials, products, process records,
Or similar enterprises in the same period detection data, etc.).
A.6 latent period refers to the initial age of the patient's contact with the carcinogen to the tumor.
Tips & Frequently Asked Questions:Question 1: How long will the true-PDF of GBZ94-2017_English be delivered?Answer: Upon your order, we will start to translate GBZ94-2017_English as soon as possible, and keep you informed of the progress. The lead time is typically 1 ~ 3 working days. The lengthier the document the longer the lead time. Question 2: Can I share the purchased PDF of GBZ94-2017_English with my colleagues?Answer: Yes. The purchased PDF of GBZ94-2017_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet. Question 3: Does the price include tax/VAT?Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countriesQuestion 4: Do you accept my currency other than USD?Answer: Yes. If you need your currency to be printed on the invoice, please write an email to [email protected]. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay. Question 5: Should I purchase the latest version GBZ94-2017?Answer: Yes. Unless special scenarios such as technical constraints or academic study, you should always prioritize to purchase the latest version GBZ94-2017 even if the enforcement date is in future. Complying with the latest version means that, by default, it also complies with all the earlier versions, technically.
|